45 min overview on the 2019 current FDA regulatory landscape for regenerative medicine. I also discuss the ethical concerns and recent regulatory and legal actions in the USA.
A 45 min. talk on the 2019 Current USA Regulations for Stem Cells and the regulatory and legal actions
Posted in: Amniotic Fluid/Umbilical Cord Blood/Whartons Jelly/Placenta, Lectures, Legal Issues With Regenerative Medicine (USA) | Posted on: 17 September, 2019
Post a comment
Your email address will not be published. Fields marked (*) are mandatory.